Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon Athletica founder Chip Wilson — to push a next-generation CRISPR drug ...

Impetigo is a common contagious skin infection. Bacteria like Staphylococcus aureus or Streptococcus pyogenes infect the outer layer of your skin called the epidermis. Your face, arms, and legs ...

EPI-321, the startup’s lead program, uses CRISPR tools to stop errant expression of a gene implicated in the muscle-wasting condition. Epicrispr will start a Phase 1 trial this year in New Zealand, ...

Instead, they use a genetic system called CRISPR to defend themselves ... In the Johns Hopkins study, researchers focused on Streptococcus pyogenes, the bacteria responsible for strep throat. They ...

Scientists are studying how bacteria use CRISPR to defend themselves from phages ... In their experiments, the scientists say Streptococcus pyogenes bacteria (which cause strep throat) take advantage ...

In their experiments, the scientists say Streptococcus pyogenes bacteria (which cause ... say bacteria have long been known to use CRISPR-Cas systems to chop up phage DNA, break it down and ...

We were able to successfully package three different proteins: Streptococcus pyogenes Cas9 (spCas9), Cre recombinase, and engineered ascorbate peroxidase (APEX2). Importantly, packaged APEX2 retained ...

In their experiments, the scientists say Streptococcus pyogenes bacteria (which cause ... say bacteria have long been known to use CRISPR-Cas systems to chop up phage DNA, break it down and ...

Scientists are studying how bacteria use CRISPR to defend themselves from phages ... In their experiments, the scientists say Streptococcus pyogenes bacteria (which cause strep throat) take advantage ...

The system is also highly efficient, comparable to the widely used Streptococcus pyogenes CRISPR-Cas9. Streptococcus pyogenes is the bacterial species on which CRISPR-Cas9 and most subsequent research ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...